← All trials
NCT01021878
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 31, 2009
- Primary completion
- Nov 30, 2011
- Completion date
- Feb 29, 2012
- First posted
- Nov 30, 2009
- Last posted
- Oct 1, 2014
- Enrollment
- 60
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Pontifícia Universidade Católica do ParanáLead sponsor
- BaxaltaCollaborator
- Pontifícia Universidade Católica do ParanáReponsible party - principal investigator
- Pontifícia Universidade Católica do ParanáSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.